T. J. Gregory

Publication List Details

Period

1990 - 1990

Number

9

Co-Authors

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160 (1990)

Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., ...

The development of a vaccine to provide protective immunity to human immunodeficiency virus type 1 (HIV-1), the virus causing AIDS, would be the most practical method to control its spread. Subunit...

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.

Ashkenazi, A, Smith, D H, Marsters, S A, Riddle, L, Gregory, T J, Ho, D D, ...

The infection of human cells by laboratory strains of human immunodeficiency virus type 1 (HIV-1) can be blocked readily in vitro by recombinant soluble CD4 and CD4-immunoglobulin hybrid molecules....

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

Gorse, G J, Patel, G B, Newman, F K, Belshe, R B, Berman, P W, Gregory, T J, ...

The ability of antibody induced by MN and IIIB recombinant gp120 (rgp120) human immunodeficiency virus type 1 (HIV-1) vaccines the bind to oligomeric native and monomeric recombinant HIV-1 envelope...

Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.

Byrn, R A, Sekigawa, I, Chamow, S M, Johnson, J S, Gregory, T J, Capon, D J, ...

The first step in infection of human T cells with human immunodeficiency virus (HIV) is binding of viral envelope glycoprotein gp120 to its cellular receptor, CD4. The specificity of this interaction...

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

Gregory, T J, Longmore, W J, Moxley, M A, Whitsett, J A, Reed, C R, Fowler, A A, ...

Acute Respiratory Distress Syndrome (ARDS) is characterized by lung injury and damage to the alveolar type II cells. This study sought to determine if endogenous surfactant is altered in ARDS....

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.

Ashkenazi, A, Smith, D H, Marsters, S A, Riddle, L, Gregory, T J, Ho, D D, ...

The infection of human cells by laboratory strains of human immunodeficiency virus type 1 (HIV-1) can be blocked readily in vitro by recombinant soluble CD4 and CD4-immunoglobulin hybrid molecules....

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

Gorse, G J, Patel, G B, Newman, F K, Belshe, R B, Berman, P W, Gregory, T J, ...

The ability of antibody induced by MN and IIIB recombinant gp120 (rgp120) human immunodeficiency virus type 1 (HIV-1) vaccines the bind to oligomeric native and monomeric recombinant HIV-1 envelope...

Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.

Byrn, R A, Sekigawa, I, Chamow, S M, Johnson, J S, Gregory, T J, Capon, D J, ...

The first step in infection of human T cells with human immunodeficiency virus (HIV) is binding of viral envelope glycoprotein gp120 to its cellular receptor, CD4. The specificity of this interaction...

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

Gregory, T J, Longmore, W J, Moxley, M A, Whitsett, J A, Reed, C R, Fowler, A A, ...

Acute Respiratory Distress Syndrome (ARDS) is characterized by lung injury and damage to the alveolar type II cells. This study sought to determine if endogenous surfactant is altered in ARDS....